Studies on in vivo induction of HIV-1 envelope-specific cytotoxic T lymphocytes by synthetic peptides from the V3 loop region of HIV-1 IIIB gp120
- 28 February 1995
- journal article
- research article
- Published by Elsevier in Cellular Immunology
- Vol. 160 (2) , 217-223
- https://doi.org/10.1016/0008-8749(95)80031-d
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- An endogenously synthesized decamer peptide efficiently primes cytotoxic T cells specific for the HIV‐1 envelope glycoproteinEuropean Journal of Immunology, 1993
- Naturally-occurring peptide antigens derived from the MHC class-I-restricted processing pathwayImmunology Today, 1991
- Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC moleculesNature, 1991
- Antiviral cytotoxic T cell response induced by in vivo priming with a free synthetic peptide.The Journal of Experimental Medicine, 1990
- In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccineNature, 1989
- Recognition of influenza A matrix protein by HLA-A2-restricted cytotoxic T lymphocytes. Use of analogues to orientate the matrix peptide in the HLA-A2 binding site.The Journal of Experimental Medicine, 1988
- The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptidesCell, 1986
- Complete nucleotide sequence of the AIDS virus, HTLV-IIINature, 1985
- Control of Influenza and Poliomyelitis with Killed Virus VaccinesScience, 1977
- Solid Phase Peptide Synthesis. I. The Synthesis of a TetrapeptideJournal of the American Chemical Society, 1963